29 January
Another paper acceptance, this time our study on the oncogenic activity of MAFG through its co-option of the MITF lineage transcription factor. This project took a village: Olga initiated the project, Michael continued it when Olga left, and Zulaida took it across the finish line after Michael left. Xiaonan, Kai, Nicol, and Harini also significantly contributed. Congratulations, everyone, on a nice story and getting this into Nature Communications.
11 January
Our manuscript describing the generation of a multi-step, immune competent genetically engineered mouse mode that closely recapitulates the progression of human uveal melanoma was accepted at Cancer Research. Xiaonan led this project and discovered phenotypic plasticity associated with aggressive, class 2 tumors. Congratulations, Xiaonan!